Publication | Closed Access

Pioglitazone, a PPAR-γ activator, attenuates the severity of cerulein-induced acute pancreatitis by modulating early growth response-1 transcription factor

InflammationTranscriptional RegulationSignal TransductionMolecular PhysiologySignaling PathwayCerulein-induced Acute PancreatitisPancreatic CancerGene ExpressionPathologyMetabolic SignalingMedicineCell BiologyCell SignalingPpar-γ Activator